{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:37:32Z","timestamp":1791851852205,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.beem.2012.09.004","type":"journal-article","created":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T12:31:02Z","timestamp":1351168262000},"page":"13-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":185,"title":["Characteristics and metabolic effects of estrogen and\u00a0progestins contained in oral contraceptive pills"],"prefix":"10.1016","volume":"27","author":[{"given":"Regine","family":"Sitruk-Ware","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2012.09.004_bib1","article-title":"Fertility, family planning, and reproductive health of U.S. women: data from the 2002 national survey of family growth","volume":"vol. 25","author":"Chandra","year":"2005"},{"key":"10.1016\/j.beem.2012.09.004_bib2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1363\/4009408","article-title":"Factors associated with contraceptive choice and inconsistent method use, United States, 2004","volume":"40","author":"Frost","year":"2008","journal-title":"Perspectives on Sexual and Reproductive Health"},{"key":"10.1016\/j.beem.2012.09.004_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajog.2005.12.007","article-title":"Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables","volume":"195","author":"Rad","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2012.09.004_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0037-1613958","article-title":"Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study","volume":"84","author":"Middeldorp","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.beem.2012.09.004_bib5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1358\/dot.2008.44.12.1299292","article-title":"Hormonal contraception: present and future","volume":"44","author":"Benagiano","year":"2008","journal-title":"Drugs of Today"},{"key":"10.1016\/j.beem.2012.09.004_bib6","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/0002-9378(90)90554-K","article-title":"Gastrointestinal metabolism of contraceptive steroids","volume":"163","author":"Back","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2012.09.004_bib7","series-title":"Pharmacology of the contraceptive steroids","first-page":"127","article-title":"Pharmacokinetics and metabolism of ethinyl estrogens","author":"Goldzieher","year":"1994"},{"key":"10.1016\/j.beem.2012.09.004_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0039-128X(88)90185-7","article-title":"Human pharmacokinetics of ethynyl estradiol 3-sulfate and 17-sulfate","volume":"51","author":"Goldzieher","year":"1988","journal-title":"Steroids"},{"key":"10.1016\/j.beem.2012.09.004_bib9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1210\/jcem-62-4-761","article-title":"Enhanced hepatic extraction of estrogens used for replacement therapy","volume":"62","author":"Steingold","year":"1986","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.09.004_bib10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/0002-9378(85)90664-7","article-title":"Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol","volume":"151","author":"Goebelsmann","year":"1985","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2012.09.004_bib11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2012.09.004_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-5122(90)90003-O","article-title":"Pharmacokinetics of oestrogens and progestogens","volume":"12","author":"Kuhl","year":"1990","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2012.09.004_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0889-8545(21)00583-0","article-title":"Non oral routes of estrogen administration","volume":"14","author":"Cedars","year":"1987","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1016\/j.beem.2012.09.004_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","article-title":"Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity","volume":"80","author":"Edelman","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/ejc.7.2.79.90","article-title":"A pharmacokinetic study with a low-dose oral contraceptive containing 20\u00a0microg ethinylestradiol plus 100\u00a0microg levonorgestrel","volume":"7","author":"Endrikat","year":"2002","journal-title":"The European Journal of Contraception & Reproductive Health Care"},{"key":"10.1016\/j.beem.2012.09.004_bib16","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2007-0026","article-title":"Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study","volume":"92","author":"Sitruk-Ware","year":"2007","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.09.004_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0960-0760(93)90010-T","article-title":"Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in\u00a0vitro","volume":"45","author":"Wild","year":"1993","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.beem.2012.09.004_bib18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jcem-62-3-536","article-title":"Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration","volume":"62","author":"De Lignieres","year":"1986","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.09.004_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejogrb.2009.11.001","article-title":"Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiolvalerate\/dienogest): a phase III trial","volume":"149","author":"Palacios","year":"2010","journal-title":"European Journal of Obstetrics, Gynecology and Reproductive Biology"},{"key":"10.1016\/j.beem.2012.09.004_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/13625180902850039","article-title":"Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest","volume":"14","author":"Zeun","year":"2009","journal-title":"The European Journal of Contraception & Reproductive Health Care"},{"key":"10.1016\/j.beem.2012.09.004_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF03190010","article-title":"Bioequivalence assessment of three different estradiol formulations in postmenopausal women in an open, randomized, single-dose, 3-way cross-over study","volume":"24","author":"Timmer","year":"1999","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.beem.2012.09.004_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0378-5122(82)90064-0","article-title":"Pharmacokinetic and pharmacological features of oestradiol valerate","volume":"4","author":"D\u00fcsterberg","year":"1982","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2012.09.004_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jsbmb.2008.12.013","article-title":"Clinical applications for estetrol","volume":"114","author":"Visser","year":"2009","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2012.09.004_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13697130802073425","article-title":"Estetrol review: profile and potential clinical applications","volume":"11","author":"Coelingh Bennink","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2012.09.004_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.contraception.2007.11.014","article-title":"Ovulation inhibition by estetrol in an in\u00a0vivo model","volume":"77","author":"Coelingh Bennink","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.beem.2012.09.004_bib27","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1073\/pnas.122225699","article-title":"Coactivator\/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486","volume":"99","author":"Liu","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.beem.2012.09.004_bib28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2165\/00003495-199651020-00002","article-title":"Comparative pharmacology of newer progestagens","volume":"51","author":"Kuhl","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.beem.2012.09.004_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1020072325818","article-title":"Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception","volume":"3","author":"Stanczyk","year":"2002","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"key":"10.1016\/j.beem.2012.09.004_bib30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0039-128X(00)00119-7","article-title":"Nestorone\u00ae: a progestin with a unique pharmacological profile","volume":"65","author":"Kumar","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.beem.2012.09.004_bib31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0039-128X(03)00140-5","article-title":"Nestorone: clinical applications for contraception and HRT","volume":"68","author":"Sitruk-Ware","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.beem.2012.09.004_bib32","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1210\/jc.2007-0044","article-title":"Formation of ethinyl estradiol in women during treatment with norethindrone acetate","volume":"9","author":"Chu","year":"2007","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.09.004_bib33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/1933719112438061","article-title":"The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis","volume":"19","author":"Chwalisz","year":"2012","journal-title":"Reproductive Science"},{"key":"10.1016\/j.beem.2012.09.004_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0010-7824(99)00101-8","article-title":"Nomenclature of the gonaneprogestins","volume":"60","author":"Edgren","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.maturitas.2008.11.013","article-title":"Classification and pharmacology of progestins","volume":"61","author":"Schindler","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2012.09.004_bib36","series-title":"Progestins and antiprogestins in clinical practice","first-page":"163","article-title":"Hybrid progestins: the example of dienogest","author":"Oettel","year":"2000"},{"key":"10.1016\/j.beem.2012.09.004_bib37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.steroids.2007.10.003","article-title":"Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile","volume":"73","author":"Sasagawa","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.beem.2012.09.004_bib38","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0002-9378(93)90332-D","article-title":"Pharmacokinetics of desogestrel","volume":"168","author":"McClamrock","year":"1993","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2012.09.004_bib39","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0002-9378(12)90410-X","article-title":"Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity","volume":"167","author":"Phillips","year":"1992","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2012.09.004_bib40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.contraception.2010.04.004","article-title":"The use of newer progestins for contraception","volume":"82","author":"Sitruk-Ware","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.steroids.2011.02.002","article-title":"Nomegestrol acetate, a novel progestogen for oral contraception","volume":"76","author":"Mueck","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.beem.2012.09.004_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0010-7824(93)90112-K","article-title":"One year contraception with a single subdermal implant containing nomegestrol acetate (Uniplant)","volume":"47","author":"Coutinho","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0960-0760(93)90105-6","article-title":"Enzyme immunoassay for nomegestrol acetate in human plasma","volume":"46","author":"Ezan","year":"1993","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.beem.2012.09.004_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0010-7824(01)00310-9","article-title":"Effect of dienogest-containing oral contraceptives on lipid metabolism","volume":"65","author":"Wiegratz","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib46","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/13625187.2011.604450","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism","volume":"16","author":"\u00c5gren","year":"2011","journal-title":"The European Journal of Contraception & Reproductive Health Care"},{"key":"10.1016\/j.beem.2012.09.004_bib47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.contraception.2003.11.003","article-title":"A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles","volume":"69","author":"Gaspard","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/09513590701325731","article-title":"Influence of a new oral contraceptive with drospirenone on lipid metabolism","volume":"23","author":"Taneepanichskul","year":"2007","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.beem.2012.09.004_bib49","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1161\/01.ATV.17.7.1216","article-title":"Effects of contraceptive estrogen and progestin on the atherogenic potential of plasma LDLs in cynomolgus monkeys","volume":"17","author":"Manning","year":"1997","journal-title":"Arteriosclerosis Thrombosis and Vascular Biology"},{"key":"10.1016\/j.beem.2012.09.004_bib50","first-page":"250","article-title":"Low-dose contraceptive estrogen\u2013progestin and coronary artery atherosclerosis of monkeys","volume":"96","author":"Adams","year":"2000","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2012.09.004_bib51","first-page":"i77","article-title":"Oral comparative effects of a four-phasic regimen of estradiol valerate\/dienogest versus ethinylestradiol\/levonorgestrel on haemostatic parameters","volume":"23","author":"Parke","year":"2008","journal-title":"Human Reproduction"},{"key":"10.1016\/j.beem.2012.09.004_bib52","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1517\/14656561003724713","article-title":"Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest","volume":"11","author":"Jensen","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.beem.2012.09.004_bib53","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/11590220-000000000-00000","article-title":"Metabolic and haemostatic effects of estradiol valerate\/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study","volume":"31","author":"Junge","year":"2011","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.beem.2012.09.004_bib54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.contraception.2005.09.015","article-title":"A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20\u00a0microg ethinyl estradiol and a reference containing desogestrel and 30\u00a0microg ethinyl estradiol","volume":"73","author":"Kluft","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0010-7824(95)00271-5","article-title":"A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20\u00a0micrograms and 30\u00a0micrograms ethinylestradiol","volume":"53","author":"Winkler","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.contraception.2004.03.004","article-title":"Effect of four oral contraceptives on hemostatic parameters","volume":"70","author":"Wiegratz","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib57","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.contraception.2008.06.015","article-title":"Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30\u00a0mcg ethinylestradiol and 2\u00a0mg dienogest on various hemostasis parameters","volume":"78","author":"Wiegratz","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib58","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1538-7836.2008.02863.x","article-title":"Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor","volume":"6","author":"van Vliet","year":"2008","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.beem.2012.09.004_bib59","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/13625189909064007","article-title":"Oral progestogen-only contraceptives and cardiovascular risk: results from the transnational study on oral contraceptives and the health of young women","volume":"4","author":"Heinemann","year":"1999","journal-title":"The European Journal of Contraception and Reproductive Health Care"},{"key":"10.1016\/j.beem.2012.09.004_bib61","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrm2391","article-title":"Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.beem.2012.09.004_bib62","doi-asserted-by":"crossref","first-page":"15644","DOI":"10.1073\/pnas.202612199","article-title":"Progesterone receptor knockout mice have an improved glucose homeostasis secondary to \u03b2-cell proliferation","volume":"99","author":"Picard","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.beem.2012.09.004_bib63","first-page":"64","article-title":"Insulin resistance, secretion, and metabolism in users of oral contraceptives","volume":"74","author":"Godsland","year":"1992","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.09.004_bib64","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(79)92949-0","article-title":"Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism","volume":"1","author":"Wynn","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.09.004_bib65","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0010-7824(91)90080-Y","article-title":"Effects of nomegestrol acetate (5\u00a0mg\/d) on hormonal, metabolic and hemostatic parameters in premenopausal women","volume":"44","author":"Basdevant","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib66","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/0002-9378(93)90432-I","article-title":"Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives","volume":"169","author":"Kojima","year":"1993","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2012.09.004_bib67","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism","volume":"323","author":"Godsland","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2012.09.004_bib68","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.contraception.2009.01.012","article-title":"Route of administration of contraceptives containing desogestrel\/etonogestrel and insulin sensitivity: a prospective randomized study","volume":"80","author":"Cagnacci","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.09.004_bib69","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.beem.2012.09.004_bib70","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jfprhc-2011-100260","article-title":"Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets","volume":"38","author":"Dinger","year":"2012","journal-title":"The Journal of Family Planning and Reproductive Health Care"},{"key":"10.1016\/j.beem.2012.09.004_bib71","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","article-title":"Risk of nonfatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data","volume":"342","author":"Jick","year":"2011","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2012.09.004_bib72","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and estrogen doses: Danish cohort study 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2012.09.004_bib73","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10","volume":"344","author":"Lidegaard","year":"2012","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2012.09.004_bib74","unstructured":"Combined hormonal contraceptives (CHCs) and the risk of cardiovascular disease endpoints (CHC-CVD final report 111022v2). http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM277384.pdf."},{"key":"10.1016\/j.beem.2012.09.004_bib75","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Annals of Internal Medicine"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X12001005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X12001005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:46:03Z","timestamp":1761497163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X12001005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1521690X12001005"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2012.09.004","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and metabolic effects of estrogen and\u00a0progestins contained in oral contraceptive pills","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2012.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}